Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review
出版年份 2021 全文链接
标题
Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review
作者
关键词
-
出版物
Translational Psychiatry
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-22
DOI
10.1038/s41398-021-01613-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clozapine in bipolar disorder: A systematic review and meta-analysis
- (2020) Andre Delgado et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics
- (2020) Jose Leon et al. World Psychiatry
- Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis
- (2020) C. Okhuijsen-Pfeifer et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies
- (2019) Xiao-Hong Li et al. PSYCHOLOGICAL MEDICINE
- Clozapine augmentation strategies – a systematic meta-review of available evidence. Treatment options for clozapine resistance
- (2019) Elias Wagner et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis
- (2019) Shih-Yu Chen et al. CNS DRUGS
- Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis
- (2019) Kurt Buhagiar et al. CLINICAL DRUG INVESTIGATION
- A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia
- (2019) Nicholas Myles et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to‐head comparisons
- (2019) Taishiro Kishimoto et al. World Psychiatry
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics
- (2019) Takahiro Masuda et al. JAMA Psychiatry
- Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis
- (2019) Clément Palpacuer et al. BMC Medicine
- Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
- (2019) Yuya Mizuno et al. NEUROPSYCHOPHARMACOLOGY
- Meta-analysis examining the epidemiology of clozapine-associated neutropenia
- (2018) N. Myles et al. ACTA PSYCHIATRICA SCANDINAVICA
- Delays and barriers to the commencement of clozapine in eligible people with a psychotic disorder: A literature review
- (2018) Kristen Thien et al. Early Intervention in Psychiatry
- Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
- (2018) Parita Shah et al. PSYCHIATRY RESEARCH
- Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years
- (2018) Jentien M Vermeulen et al. SCHIZOPHRENIA BULLETIN
- Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis
- (2018) C. Okhuijsen-Pfeifer et al. ACTA PSYCHIATRICA SCANDINAVICA
- Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis
- (2018) Andrew T. Olagunju et al. CNS DRUGS
- Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis
- (2018) Dan Siskind et al. DIABETES OBESITY & METABOLISM
- Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy of typical and atypical antipsychotic medication on hostility in patients with psychosis-spectrum disorders: a review and meta-analysis
- (2018) Margo D. M. Faay et al. NEUROPSYCHOPHARMACOLOGY
- Concerns about bias in studies on clozapine and mortality
- (2018) Y.C. van der Zalm et al. SCHIZOPHRENIA RESEARCH
- Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
- (2018) Maren Carbon et al. World Psychiatry
- Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antipsychotic drug use and pneumonia: Systematic review and meta-analysis
- (2018) O Dzahini et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis
- (2017) Zhihua Bai et al. SCHIZOPHRENIA RESEARCH
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials
- (2016) W. Zheng et al. ACTA PSYCHIATRICA SCANDINAVICA
- Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
- (2016) Dan Siskind et al. BRITISH JOURNAL OF PSYCHIATRY
- Worldwide Differences in Regulations of Clozapine Use
- (2016) Jimmi Nielsen et al. CNS DRUGS
- A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome
- (2016) Jorge Zimbron et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders
- (2016) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis
- (2016) Gail A. Alvares et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia
- (2016) Myrto T. Samara et al. JAMA Psychiatry
- Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis
- (2016) Dan J. Siskind et al. PLoS One
- Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials
- (2015) R. E. Nielsen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies
- (2015) F Salvo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
- (2015) Cenk Tek et al. Early Intervention in Psychiatry
- Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis
- (2015) Francesco Bartoli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia
- (2015) Alp Üçok et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials
- (2015) Manit Srisurapanont et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis
- (2015) Francesco Bartoli et al. PSYCHONEUROENDOCRINOLOGY
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Chlorpromazine versus every other antipsychotic for schizophrenia: A systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs
- (2014) Myrto T. Samara et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
- (2014) Maarten Bak et al. PLoS One
- Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
- (2014) S. Leucht et al. SCHIZOPHRENIA BULLETIN
- Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
- (2014) Yoshiyuki Tsuda et al. BMJ Open
- Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications
- (2013) Lisa Hartling et al. ANNALS OF INTERNAL MEDICINE
- Pseudotumor cerebri in a child treated with acitretin: A rare occurrence
- (2013) Somenath Sarkar et al. INDIAN JOURNAL OF PHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses
- (2012) Juliano S Souza et al. CNS SPECTRUMS
- Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2012) Karla Soares-Weiser et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
- (2012) Jian-Ping Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Meta-Analyses of the Efficacy of Asenapine for Acute Schizophrenia
- (2012) Armin Szegedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents
- (2012) David Cohen et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine
- (2012) Megan Sherwood et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children
- (2011) Tamara Pringsheim et al. DRUG SAFETY
- Mid-Term and Long-Term Efficacy and Effectiveness of Antipsychotic Medications for Schizophrenia
- (2011) Ira D. Glick et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Review and Bayesian Meta-Analysis of Clinical Efficacy and Adverse Effects of 4 Atypical Neuroleptic Drugs Compared With Haloperidol and Placebo
- (2011) Marianne Klemp et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics
- (2011) T Kishimoto et al. MOLECULAR PSYCHIATRY
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Autoimmune diseases, bipolar disorder, and non-affective psychosis
- (2010) William W Eaton et al. BIPOLAR DISORDERS
- A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics
- (2010) Alessandro Serretti et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
- (2010) Hilda Bastian et al. PLOS MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology
- (2009) GM Goodwin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis
- (2008) M. Smith et al. BRITISH JOURNAL OF PSYCHIATRY
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
- (2008) S Leucht et al. MOLECULAR PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now